Neuraxis Inc. (NYSE AMERICAN: NRXS) Stock Information | RedChip

Neuraxis Inc. (NYSE AMERICAN: NRXS) Listen to this Section


$3.14
+0.0050 ( +0.16% ) 1.8K

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Market Data


Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 45 Sep 21, 2023
3 Insider transactions 1 Sep 13, 2023
8-k 8K-related 31 Aug 17, 2023
4/a Other 1 Aug 11, 2023
4 Insider transactions 1 Aug 10, 2023
3 Insider transactions 1 Aug 09, 2023
3 Insider transactions 1 Aug 09, 2023
8-k 8K-related 15 Aug 09, 2023
3 Insider transactions 1 Aug 09, 2023
3 Insider transactions 1 Aug 08, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.